A clinical trial investigating the treatment TIVDAK for cervical cancer has shown positive results. The topline results from the global Phase 3 innovaTV 301 study demonstrated...
Innovative Birmingham-based nutrition firm Rem3dy Health has been recognised in the first-ever “Sunday Times 100 Tech: Britain’s fastest-growing private technology companies” list. The new rankings were...
A new, at-home cervical cancer screening test will be launched with the backing of US$10m in funding. The Teal Wand, a at-home screening device and telehealth...
Researchers have discovered that the loss of oestrogen and progesterone during menopause causes damage to bone cartilage and the cells that maintain it. However, they also...
The recent Women and Equalities Committee (WEC) report further highlighted how the UK public healthcare system is failing to meet the needs of women—now they want...
A clinical trial has found that, in patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of...
Future Fertility has developed a significant advancement in reproductive care with the launch of Euploidy Insights. This clinically validated, non-invasive tool analyses freshly retrieved oocytes to predict...
Researchers have discovered how specific protein regions contribute to breast cancer, potentially paving the way for new treatment. The discovery also offers scientists new tools and...
The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women’s health innovation. We will be celebrating some...
A new femtech-focussed accelerator has been launched, called, Alpha Startups Inno4Her, in South East Asia by Malaysia-based venture capital firm, 1337 Ventures. With the femtech market...
